Cancer Stem Cell News 9.17 May 6, 2020 | |
![]() | |
| |
TOP STORYTrifluoperazine (TFP) caused loss of radiation-induced nanog mRNA expression, and activation of GSK3 with consecutive posttranslational reduction in p-Akt, Sox2, and β-catenin protein levels. TFP did not alter the intrinsic radiation sensitivity of glioma-initiating cells. [Proc Natl Acad Sci USA] Abstract | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists showed that tumor cells exhibiting stem-like properties and expression of pluripotency markers NANOG and OCT4 could arise from original differentiated tumor cells freshly isolated from human glioblastomas and which had never known any serum culture conditions. [Cancer Res] Abstract Investigators characterized the effect of the loss-of-function of Notchless, an essential actor of ribosome biogenesis, on the intestinal epithelium undergoing tumor initiation due to acute Apc loss-of-function. [Cell Death Differ] Abstract By detecting CD133+ cells and carrying out sphere culture assays, researchers found that knockdown of YTHDF2 led to impaired stemness in Hep3B and Huh7 cells. [Oncogene] Abstract Ionizing radiation induced cellular export of miR-603 through EV release, thereby de-repressing IGF1 and IGF1R. This de-repression, in turn, promoted CSC state and acquired radiation resistance in glioblastomas. [EBioMedicine] Full Article | Graphical Abstract Stearoyl-CoA desaturase-1 (SCD1) was found to increase the population of gastric cancer stem cells (GCSCs), whereas its suppression by an SCD1 inhibitor or knockdown by siRNA attenuated the stemness of GCSCs, including chemotherapy resistance and sphere-forming ability. [Br J Cancer] Abstract Ki67 staining, colony formation and trypan blue staining assays revealed that prostate cancer associated transcript 6 (PCAT6) boosted gastrointestinal stromal tumor (GIST) cell proliferation but inhibited cell apoptosis. PCAT6 promoted GIST cell proliferation and stemness via sponging miR-143-3p to upregulate peroxiredoxin 5. [Mol Carcinog] Abstract Syndecan-1 depletion cooperatively enhanced activation of integrins and focal adhesion kinase, which then generated signals for increased invasiveness and CSC properties. [FEBS J] Abstract | Download Full Article The Limitations of Targeting MEK Signaling in Glioblastoma Therapy Trametinib had a strong anti-proliferative effect on established glioblastoma cell lines, stem cell-like cells and their differentiated progeny and while it did not enhance anti-proliferative and cell death-inducing properties of the standard treatment. [Sci Rep] Full Article Sphere formation assay was performed to evaluate the effect of sevoflurane on the stemness of glioma stem cells (GSCs). Sphere formation ability of GSCs, expression levels of stemness markers and mitochondrial function were significantly suppressed by sevoflurane. [Life Sci] Abstract Researchers report a novel function of B-cell lymphoma 3 (Bcl-3) in maintaining colorectal cancer stem cell homeostasis by activating Wnt/β-catenin signaling. [Signal Transduct Target Ther] Full Article Subscribe to one of our other 19 science newsletters such as Neural Cell News & Hematopoiesis News. | |
| |
REVIEWSThe Effects of Microgravity on Differentiation and Cell Growth in Stem Cells and Cancer Stem Cells The authors review the current knowledge of different types of stem cells exposed to μg conditions with regard to differentiation and engineering of cartilage, bone, vasculature, heart, skin, and liver constructs. [Stem Cells Transl Med] Full Article Visit our reviews page to see a complete list of reviews in the cancer stem cell research field. | |
| |
INDUSTRY NEWSDelMar Pharmaceuticals, Inc. announced it has enrolled 22 patients in the adjuvant arm of the company’s ongoing Phase II clinical study investigating adjuvant treatment of MGMT-unmethylated glioblastoma multiforme with VAL-083. [DelMar Pharmaceuticals, Inc.] Press Release TG Therapeutics, Inc. announced positive topline results from the global UNITY-CLL Phase III trial evaluating the combination of umbralisib plus ublituximab compared to obinutuzumab plus chlorambucil in patients with previously untreated and relapsed/refractory chronic lymphocytic leukemia (CLL). [TG Therapeutics, Inc.] Press Release | |
| |
POLICY NEWS‘It Will Not Be Easy.’ as Labs Begin to Reopen, Enormous Challenges Remain One of the biggest challenges labs face is how to keep their members physically distanced to limit any potential spread of SARS-CoV-2. [ScienceInsider] Editorial Coronavirus: Share Lessons on Lifting Lockdowns Countries are starting to lift restrictions on movement, but there is little consensus on how this should be done. Sharing best practice is the way forward. [Nature News] Editorial
| |
EVENTSIn light of COVID-19, many conferences are being cancelled or postponed. As such: We are suspending new event postings in our newsletters and on Twitter. Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESAssistant Professor – Cell Cycle and Cancer Biology (Oklahoma Medical Research Foundation) Postdoctoral Fellowship – Leukemia Stem Cell Research (Josep Carreras Leukaemia Research Institute) Scientist – Stem Cells and Cellular Biology (Athersys, Inc.) Postdoctoral Positions – DNA Repair in Leukemia (Temple University School of Medicine) Postdoctoral Position – Glioma Epigenomic Research (NIH National Cancer Institute) Postdoctoral Fellow – RAS Proteins and Cancer Cell Stemness (University of Luxembourg) Postdoctoral Position – Leukemia and Cancer Stemness (Moores Cancer Center, UC San Diego) Postdoctoral Fellow – Breast Cancer Stem Cells (Albert Einstein College of Medicine) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|